Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/24/2024 | $9.50 | Overweight | Cantor Fitzgerald |
5/26/2023 | $11.00 | Hold → Buy | Kepler |
3/25/2022 | $20.00 | Buy → Neutral | Bryan Garnier |
10/20/2021 | $28.00 | Overweight | JP Morgan |
9/2/2021 | $30.00 | Buy | Stifel |
8/9/2021 | $30.00 | Buy | Lake Street |
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of sophisticated 3D printing services, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Highlights – Fourth Quarter 2024 Total revenue increased 0.6% to 65,680 kEUR for the fourth quarter of 2024 from 65,295 kEUR for the corresponding 2023 period boosted by 14.3% growth in our Materialise Medical segment. Total deferred revenues from software maintenance and license fees increased by 5,878 kEUR this quarter to 46,948 kEUR. Adjusted EBITDA amounted to 4,306 kEUR for the fourth quarter of 2024 compared to 8,474 kEUR for the cor
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the fourth quarter ended December 31, 2024 on Thursday, February 20, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2024 financial results on Thursday, February 20, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's confe
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the third quarter ended September 30, 2024. Highlights – Third Quarter 2024 Total revenue increased 14.2% to 68,652 kEUR compared to 60,130 kEUR for the third quarter of 2023. Gross profit as a percentage of revenue for the third quarter of 2024 was 57.2%, compared to 56.0% for the third quarter of 2023. Adjusted EBIT increased to 4,408 kEUR for the third quarter of 2024 from 2,330 kEUR for the 2023 period, while Adjusted EBITDA increased to 9,895 kEUR for the third quarter of 2024 from 7,857 kEUR for the
SC 13G/A - MATERIALISE NV (0001091223) (Subject)
SC 13G/A - MATERIALISE NV (0001091223) (Subject)
SC 13G/A - MATERIALISE NV (0001091223) (Subject)
6-K - MATERIALISE NV (0001091223) (Filer)
6-K - MATERIALISE NV (0001091223) (Filer)
6-K - MATERIALISE NV (0001091223) (Filer)
Cantor Fitzgerald initiated coverage of Materialise with a rating of Overweight and set a new price target of $9.50
Kepler upgraded Materialise from Hold to Buy and set a new price target of $11.00
Bryan Garnier downgraded Materialise from Buy to Neutral and set a new price target of $20.00
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of sophisticated 3D printing services, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Highlights – Fourth Quarter 2024 Total revenue increased 0.6% to 65,680 kEUR for the fourth quarter of 2024 from 65,295 kEUR for the corresponding 2023 period boosted by 14.3% growth in our Materialise Medical segment. Total deferred revenues from software maintenance and license fees increased by 5,878 kEUR this quarter to 46,948 kEUR. Adjusted EBITDA amounted to 4,306 kEUR for the fourth quarter of 2024 compared to 8,474 kEUR for the cor
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the fourth quarter ended December 31, 2024 on Thursday, February 20, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2024 financial results on Thursday, February 20, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's confe
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the third quarter ended September 30, 2024. Highlights – Third Quarter 2024 Total revenue increased 14.2% to 68,652 kEUR compared to 60,130 kEUR for the third quarter of 2023. Gross profit as a percentage of revenue for the third quarter of 2024 was 57.2%, compared to 56.0% for the third quarter of 2023. Adjusted EBIT increased to 4,408 kEUR for the third quarter of 2024 from 2,330 kEUR for the 2023 period, while Adjusted EBITDA increased to 9,895 kEUR for the third quarter of 2024 from 7,857 kEUR for the
Fried Vancraen, Co-founder and CEO, to become Chairman of the Board Materialise NV (NASDAQ:MTLS), a global leader in 3D printing software and services, today announced that the company's Board of Directors has appointed Brigitte de Vet-Veithen as Chief Executive Officer. Brigitte de Vet-Veithen will succeed Fried Vancraen, who co-founded Materialise in 1990 and has served as the company's CEO for 33 years. Mr. Vancraen will continue to represent Materialise as the new Chairman of the Board of Directors. The leadership transition will become effective on January 1, 2024, as part of the management changes described below. "We founded Materialise with a mission to create a better and healt